Appointment

1. Antonin (Tony) de Fougerolles, Etherna  Antonin (Tony) de Fougerolles has joined the Etherna board of directors as an independent member.  He is currently the CEO of Evox Therapeutics. As founding Chief Scientific Officer (CSO) at Moderna Therapeutics, he pioneered modified mRNA.  2. Dr Xavier Jacq, Ubiquigent Ubiquigent has appointed Dr Xavier Jacq to its […]

News round-up by DDW Editor Reece Armstrong for 15-19 August. Covid booster approvals, positive results for Malaria vaccines and new CEOs are some of the stories in this week’s news round-up.  MHRA approves Moderna’s bivalent Covid booster   The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s Covid-19 booster vaccine […]

Clinical-stage company Respira Technologies has appointed a new Chief Executive Officer (CEO) to the company.  Brian Quigley will take over as CEO after working as Respira’s Chief Operating Officer (COO) for the past two years.   Quigley previously worked at Altria Group for 16 years where he spent seven years as President & CEO at Altria’s […]

Biopharmaceutical company TikoMed has announced two new appointments to its Board of Directors as the company focuses on its ILB drug programme. TikoMed has appointed Tara Heitner and Pete Zorn to its Board of Directors. Tara Heitner has more than 15 years of experience in the biopharmaceutical industry and has been involved in the development […]

Techbio company Closed Loop Medicines has appointed two new members in support of its planned international growth.   Closed Loop Medicines appointed David Van Sickle as Non-Executive Director and Simon Ramsden as Chief Financial Officer.  Closed Loop Medicine says that the hires will help in the next stage of its growth as the company expands its […]

Biotechnology company Complement Therapeutics has appointed a new member to its board to help support the company with its development goals.   Complement Therapeutics appointed Steve Axon as in independent director to its Board of Directors who will help the company with its goals of addressing unmet needs in complement mediated diseases such as geographic atrophy due […]

News round-up by DDW’s Reece Armstrong for 20-24 June. Covid-19 vaccine development and research, gene therapies for dementia and a ‘game-changing’ treatment for HIV are some of the themes of this week’s news round-up. Moderna to set up mRNA vaccine centre in UK  Pharmaceutical company Moderna is to set-up a manufacturing and research development centre […]

Precision medicine technologies company Iterative Scopes has appointed a new Chief Technology Officer (CTO) to help lead the business’ machine learning offerings.   Dr Aditya Khosla has joined the team as CTO and as a member of Iterative Scopes’ board of directors. In his role as CTO, Dr Khosla will lead Iterative Scopes’ machine learning, product management, […]

The Pistoia Alliance has appointed its first female President with Dr Becky Upton taking on the position, the organisation has announced.  Dr Upton will lead the not-the-profit’s strategy with a focus on areas of increasing importance such as data standards, diversity and inclusion, sustainability and precision medicine.  Dr Upton aims to continue the Pistoia Alliance’s […]

Synthetic biology company Evonetix has appointed a new Chief Executive Officer (CEO) to support the company’s next phase of product development.   The company has appointed Colin McCracken as CEO with immediate effect. McCracken has over 20 years of experience and will support Evonetix in the development and commercialisation of its semiconductor-based DNA synthesis platform.  Prior […]